No. of cases | Falciparum (%) | Location of travel | Non-immune (%) | Immune (%) | Thrombocytopaenia total <150 | Hepatomegaly and/or splenomegaly (%) | |
---|---|---|---|---|---|---|---|
1 | Ladhani et al1 (290 patients) | 85 | 90% Africa | 68 | 32 | 57% | Not investigated |
2 | Ladhani et al4 (211 patients) | 91 | 94% Africa | 82 | 18 | 64% | 60% |
3 | Arnáez et al7 (60 patients) | 72 | 98% Africa | 77 | 23 | 45% | 77% |
4 | Leahy et al10 (66 patients) | 97 | 97% Africa | 52 | 48 | Not investigated | Not investigated |
5 | Chalumeau et al11 (29 patients) | 100 | 100% Africa | 100 | 0 | 62% | 20% |
Total | 656 patients | 88 | 93% Africa | 74 | 26 | 59% | 59% |